Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial
- DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators
Research output: Contribution to journal › Article › peer-review
1659
Citations
(SciVal)